The Drug Regulatory Authority of Pakistan (DRAP), in collaboration with the World Health Organization (WHO), has conducted awareness seminars at various educational institutions under the Pharmacovigilance Awareness and Outreach Plan and in observance of #MedSafetyWeek.
The seminars were held for faculty members, students and healthcare professionals at King Edward Medical University Lahore, University of Veterinary and Animal Sciences Lahore, Capital University of Science and Technology (CUST) Islamabad, Allama Iqbal Medical College Lahore, and Lahore College for Women University Lahore.
During the sessions, participants were briefed on the pharmacovigilance process, the importance of reporting adverse events, and the available reporting channels for submitting reports to the National and Provincial Pharmacovigilance Centres.
Participants expressed their commitment to strengthening adverse event reporting and contributing to the safer use of medicines.
In addition to the seminars, the DRAP-WHO team held meetings with the Vice Chancellors of King Edward Medical University and the University of Veterinary and Animal Sciences. The meetings focused on exploring opportunities to integrate pharmacovigilance into the curricula of relevant healthcare disciplines and promote awareness among undergraduate students.
The team also engaged with the Directors of the Punjab Healthcare Commission (PHC) to discuss strengthening adverse event reporting through VigiFlow and VigiMobile. The use of standardised reporting forms as part of the implementation of Minimum Service Delivery Standards (MSDS) was also discussed.
The initiative aimed to promote a culture of reporting and strengthen pharmacovigilance to support safer use of medicines in Pakistan.
